From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM
| dc.contributor.author | Elmaci, Ilhan | |
| dc.contributor.author | Ozpinar, Aysel | |
| dc.contributor.author | Ozpinar, Alp | |
| dc.contributor.author | Perez, Jennifer L. | |
| dc.contributor.author | Altinoz, Meric A. | |
| dc.date.accessioned | 2025-10-16T15:23:47Z | |
| dc.date.issued | 2019 | |
| dc.identifier.doi | 10.1007/s11011-019-00412-5 | |
| dc.identifier.other | WOS:000468070600001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/8013 | |
| dc.publisher | SPRINGER/PLENUM PUBLISHERS | |
| dc.source | METABOLIC BRAIN DISEASE | |
| dc.subject | Glioblastoma | |
| dc.subject | Glioma | |
| dc.subject | Vitamin D | |
| dc.subject | Vitamin a | |
| dc.subject | Temozolomide | |
| dc.title | From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM | |
| dc.type | Review |
